Evidence map›Paper›PMID 26106425›Full record

ReviewStem cells international2015

Recent Advances in Hydroxyapatite Scaffolds Containing Mesenchymal Stem Cells.

John Michel, Matthew Penna, Juan Kochen, Herman Cheung

Abstract readReview
In one paragraph

Review in Stem cells international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Sintered fluorapatite scaffolds as an autograft-like engineered bone graft.Journal of biomedical materials research. Part B, Applied biomaterials · 2024
    Article
  8. Chitin scaffolds derived from the marine demospongeFrontiers in bioengineering and biotechnology · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Bioceramics and bone healing.EFORT open reviews · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Mineralization at Titanium Surfaces is a Two-Step Process.Journal of functional biomaterials · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

John MichelDepartment of Biomedical Engineering, College of Engineering, University of Miami, 1251 Memorial Drive, MEA 219A, Coral Gables, FL 33146, USA.
Matthew PennaDepartment of Biomedical Engineering, College of Engineering, University of Miami, 1251 Memorial Drive, MEA 219A, Coral Gables, FL 33146, USA.
Juan KochenDepartment of Biomedical Engineering, College of Engineering, University of Miami, 1251 Memorial Drive, MEA 219A, Coral Gables, FL 33146, USA.
Herman CheungDepartment of Biomedical Engineering, College of Engineering, University of Miami, 1251 Memorial Drive, MEA 219A, Coral Gables, FL 33146, USA ; Geriatric Research, Education and Clinical Center (GRECC), Miami Veterans Affairs Medical Center, 1201 NW 16th Street, Miami, FL 33125, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modern day tissue engineering and cellular therapies have gravitated toward using stem cells with scaffolds as a dynamic modality to aid in differentiation and tissue regeneration. Mesenchymal stem cells (MSCs) are one of the most studied stem cells used in combination with scaffolds. These cells differentiate along the osteogenic lineage when seeded on hydroxyapatite containing scaffolds and can be used as a therapeutic option to regenerate various tissues. In recent years, the combination of hydroxyapatite and natural or synthetic polymers has been studied extensively. Due to the interest in these scaffolds, this review will cover the wide range of hydroxyapatite containing scaffolds used with MSCs for in vitro and in vivo experiments. Further, in order to maintain a progressive scope of the field this review article will only focus on literature utilizing adult human derived MSCs (hMSCs) published in the last three years.

Identifiers

PMID26106425
PMCPMC4464687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.